{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T04:14:17Z","timestamp":1770524057783,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T00:00:00Z","timestamp":1696550400000},"content-version":"vor","delay-in-days":158,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.diabres.2023.110679","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T21:15:51Z","timestamp":1682198151000},"page":"110679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2422-3041","authenticated-orcid":false,"given":"Stefano","family":"Ciardullo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3024-0457","authenticated-orcid":false,"given":"Gianluca","family":"Perseghin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.110679_b0005","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2023.110679_b0010","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2023.110679_b0015","doi-asserted-by":"crossref","unstructured":"Ciardullo S, Perseghin G. Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population. 2021.","DOI":"10.1111\/liv.14828"},{"key":"10.1016\/j.diabres.2023.110679_b0020","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.diabres.2023.110679_b0025","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2023.110679_b0030","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2023.110679_b0035","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2023.110679_b0040","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2023.110679_b0045","first-page":"33","article-title":"Advances in fibrosis biomarkers in nonalcoholic fatty liver disease","volume":"106","author":"Ciardullo","year":"2021","journal-title":"Adv Clin Chem"},{"key":"10.1016\/j.diabres.2023.110679_b0050","doi-asserted-by":"crossref","unstructured":"Loomba R, Adams LA. Advances in non-invasive assessment of hepatic fibrosis. Gut. 2020:gutjnl-2018-317593.","DOI":"10.1136\/gutjnl-2018-317593"},{"key":"10.1016\/j.diabres.2023.110679_b0055","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-019-0144-8","article-title":"Past, present and future perspectives in nonalcoholic fatty liver disease","volume":"16","author":"Sanyal","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2023.110679_b0060","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2023.110679_b0065","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/apt.14621","article-title":"Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH","volume":"47","author":"Boursier","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.diabres.2023.110679_b0070","article-title":"Development and validation of a score for fibrotic nonalcoholic steatohepatitis","author":"Tavaglione","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2023.110679_b0075","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2337\/dc20-1778","article-title":"High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes","volume":"44","author":"Ciardullo","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110679_b0080","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabres.2023.110679_b0085","article-title":"Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis","volume":"109981","author":"Ciardullo","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110679_b0090","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/liv.15406","article-title":"Fibrosis nonalcoholic steatohepatitis index validation and applicability considering glycaemic severity and T2D duration","volume":"42","author":"Pina","year":"2022","journal-title":"Liver Int"},{"key":"10.1016\/j.diabres.2023.110679_b0095","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc19-1071","article-title":"Performance of plasma biomarkers and diagnostic panels for nonalcoholic steatohepatitis and advanced fibrosis in patients with type 2 diabetes","volume":"43","author":"Bril","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110679_b0100","unstructured":"Centers for disease control and prevention. 2017: National Health and Nutrition Examination Survey (NHANES). U.S. Department of health and human services. Available from https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/default.aspx?BeginYear=2017. 2017."},{"key":"10.1016\/j.diabres.2023.110679_b0105","unstructured":"NHANES Analytic Guidance and Brief Overview for the 2017-March 2020 Pre-pandemic Data Files https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/continuousnhanes\/OverviewBrief.aspx?Cycle=2017-2020 (accessed Febraury 02 2022)."},{"key":"10.1016\/j.diabres.2023.110679_b0110","unstructured":"National Center for Health Statistics. National Health and Nutrition Examination Survey 2017-2018 Laboratory Data. Internet:https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/Search\/DataPage.aspx?Component=Laboratory&CycleBegin (accessed June 2020)."},{"key":"10.1016\/j.diabres.2023.110679_b0115","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2023.110679_b0120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.diabres.2023.110679_b0125","unstructured":"Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). NHANES 1999-2000 Laboratory Procedure Manual: Glycohemoglobin."},{"key":"10.1016\/j.diabres.2023.110679_b0130","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142020","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110679_b0135","doi-asserted-by":"crossref","unstructured":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41:S13-s27.","DOI":"10.2337\/dc18-S002"},{"key":"10.1016\/j.diabres.2023.110679_b0140","doi-asserted-by":"crossref","unstructured":"Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156:1264-81.e4.","DOI":"10.1053\/j.gastro.2018.12.036"},{"key":"10.1016\/j.diabres.2023.110679_b0145","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of FibroScan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2023.110679_b0150","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gut.2010.221382","article-title":"Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years","volume":"60","author":"Roulot","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.diabres.2023.110679_b0155","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/gut.2010.234203","article-title":"Screening the general population for cirrhosis using transient elastography: finding a needle in a haystack?","volume":"60","author":"Castera","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.diabres.2023.110679_b0160","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41401-021-00822-1","article-title":"Current status and challenges in the drug treatment for fibrotic nonalcoholic steatohepatitis","volume":"43","author":"Shi","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"1147\u201359","key":"10.1016\/j.diabres.2023.110679_b0165","first-page":"e5","article-title":"Elafibranor, an agonist of the peroxisome proliferator\u2212 activated receptor\u2212 \u03b1 and\u2212 \u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.diabres.2023.110679_b0170","first-page":"107","article-title":"The clinical utility of FibroScan\u00ae as a noninvasive diagnostic test for liver disease","volume":"7","author":"Wilder","year":"2014","journal-title":"Medical Devices (Auckland, NZ)"},{"key":"10.1016\/j.diabres.2023.110679_b0175","doi-asserted-by":"crossref","unstructured":"Srivastava A, Gailer R, Tanwar S, Trembling P, Parkes J, Rodger A, et al. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. J Hepatol. 2019;71:371-8.","DOI":"10.1016\/j.jhep.2019.03.033"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723004400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723004400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:28:18Z","timestamp":1759174098000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723004400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":35,"alternative-id":["S0168822723004400"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110679","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110679"}}